Klaus Liefeith | Medicine and Dentistry | Best Researcher Award

Published on by Cognitive Scientist Awards

Best Researcher Award

Klaus Liefeith
Researcher Klaus Liefeith
Affiliation Institute for Bioprocessing and Analytical Measurement Techniques e.V.
Country Germany
Scopus ID 6602970287
Documents 95
Citations 1811
h-index 21
Subject Area Medicine and Dentistry
Event International Cognitive Scientists Award
ORCID 0000-0002-8122-4481

Klaus Liefeith
Institute for Bioprocessing and Analytical Measurement Techniques e.V.

Klaus Liefeith is a German researcher affiliated with the Institute for Bioprocessing and Analytical Measurement Techniques e.V. and is recognized for his scientific contributions within the fields of biomaterials, regenerative medicine, tissue engineering, and biomedical technologies. His scholarly work has contributed to the advancement of translational medical research, particularly through the development of innovative materials and analytical approaches designed to support healthcare applications. Based on publication records indexed in Scopus, his research output demonstrates sustained academic productivity and measurable scholarly influence through citations and collaborative scientific engagement.[1]

Abstract

This article presents an academic overview of Klaus Liefeith and his research achievements in the areas of biomaterials, biomedical engineering, regenerative medicine, and applied medical sciences. Through a documented publication record consisting of 95 indexed documents and more than 1,800 citations, Liefeith has contributed to scientific understanding in areas associated with tissue regeneration, medical devices, biofunctional materials, and analytical measurement technologies. His research portfolio reflects interdisciplinary collaboration and sustained scholarly activity that supports innovation in healthcare and medical research.[1]

Keywords

Biomaterials, Regenerative Medicine, Tissue Engineering, Biomedical Engineering, Medical Devices, Analytical Measurement Techniques, Translational Research, Medicine and Dentistry, Research Impact, Scientific Innovation.

Introduction

The advancement of modern healthcare increasingly depends on interdisciplinary scientific research that combines biological sciences, engineering principles, and material innovations. Researchers operating at the interface of these disciplines play a significant role in developing technologies that improve diagnostic, therapeutic, and regenerative medical practices. His research activities are associated with the translation of laboratory discoveries into practical healthcare solutions, contributing to broader scientific progress in medicine and dentistry.[2]

Research Profile

Liefeith’s professional profile demonstrates sustained involvement in applied biomedical research. Working within the Institute for Bioprocessing and Analytical Measurement Techniques e.V., His work reflects an interdisciplinary approach that integrates engineering concepts with biological systems to address contemporary healthcare challenges. The diversity of his publication record illustrates active participation in international scientific discussions and collaborative research networks.[1]

Research Contributions

  • Development and characterization of biomaterials suitable for biomedical and regenerative applications.
  • Research on tissue engineering scaffolds designed to support cellular growth and tissue regeneration.
  • Contributions to analytical measurement techniques relevant to biological and medical investigations.
  • Investigation of biofunctional surfaces intended to improve interactions between materials and biological systems.
  • Participation in collaborative studies supporting translational medicine and healthcare innovation.[3]

Publications

According to available indexing databases, Klaus Liefeith has authored and co-authored numerous peer-reviewed publications across biomedical and materials science disciplines. His publication record includes articles examining biomaterials, tissue engineering constructs, regenerative therapies, analytical technologies, and biomedical surface modifications. These publications have been disseminated through international scientific journals and conference proceedings, facilitating knowledge exchange within the global research community.[1]

Research Impact

Research impact may be assessed through scholarly indicators including publication volume, citation frequency, and h-index performance. With 95 indexed documents, 1,811 citations, and an h-index of 21, Liefeith’s academic record demonstrates sustained visibility within the scientific literature. These indicators suggest that his work has been referenced by researchers across multiple disciplines and continues to contribute to ongoing scientific investigations. Citation activity further reflects the relevance of his research outputs to current developments in biomedical science and healthcare innovation.[1]

Award Suitability

The Best Researcher Award recognizes sustained scientific excellence, impactful scholarship, and meaningful contributions to academic advancement. Klaus Liefeith’s publication portfolio, citation record, interdisciplinary research engagement, and contributions to biomedical innovation align with several criteria commonly associated with distinguished research recognition. His work demonstrates continued commitment to scientific inquiry and practical healthcare applications, supporting the objectives of the International Cognitive Scientists Award program.[1][4]

Conclusion

Klaus Liefeith represents an established contributor to biomedical and regenerative medicine research. Through extensive scholarly activity, interdisciplinary collaboration, and the development of innovative biomaterial solutions, he has participated in advancing scientific knowledge relevant to healthcare and medical technology. His documented publication and citation record, together with his contributions to translational biomedical research, provide a foundation supporting recognition within the Best Researcher Award category. Continued engagement in scientific investigation is expected to further contribute to the evolution of biomedical sciences and related healthcare applications.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Klaus Liefeith, Author ID 6602970287. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602970287
  2. ORCID. (n.d.). Klaus Liefeith Research Profile.
    https://orcid.org/0000-0002-8122-4481
  3. Liefeith, K. et al. Research in biomaterials and regenerative medicine.
    DOI: https://doi.org/10.1016/j.actbio.2012.07.017
  4. International Cognitive Scientists Award. (n.d.). Award Information and Recognition Criteria.
    https://cognitivescientist.org/

Hans-Werner Denker | Developmental Biology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Dr. Hans-Werner Denker | Developmental Biology | Best Researcher Award

Professor | Universität Duisburg-Essen, Germany

Prof. Dr. Hans-Werner Denker is a distinguished Professor specializing in developmental biology, embryology, and stem cell research. His work focuses on embryo implantation, epithelial-mesenchymal transition (EMT), and ethical aspects of embryoid research. With 2,606 citations, 120 publications, and an h-index of 30, he has made significant contributions to reproductive biology and developmental science.

Citation Metrics

3000

2000

1000

0

Citations 2606

Documents
120

h-index
30

 

View Scopus Profile View ORCID Profile View Google Scholar Profile

 

Featured Publications

Twenty Years on for The Epithelial-Mesenchymal Transition International Association (TEMTIA): An Interview with Co-Founders Erik Thompson and Donald Newgreen
– 2 Citations

Autonomy in the Development of Stem Cell-Derived Embryoids: Sprouting Blastocyst-Like Cysts, and Ethical Implications
– 15 Citations

Rise of the Rabbit Model for Implantation Research: A Commemoration of the Scientific Work of Bent G. Boving (1920–2019)
– 1 Citation

Recent Embryo Twinning Data Prompt Reconsideration of Theories on a Crucial Role of Segregation of Oocyte Cytoplasmic Constituents in Mammals
– Molecular Human Reproduction, 2020 | 3 Citations

Stem Cell-Derived Organoids, Embryoids, and Embryos: Advances in Organismic Development In Vitro and Ethical Considerations
– 2 Citations

Shanshan Liang | Medicine and Dentistry | Research Excellence Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Shanshan Liang | Medicine and Dentistry | Research Excellence Award

Peking University | China

Assist. Prof. Dr. Shanshan Liang is an accomplished researcher at Peking University specializing in precision dentistry and biomedical engineering, integrating artificial intelligence, robotics, ultrafast lasers, and biomaterials for advanced diagnostics and therapeutics. Her work spans digital dentistry, laser-based surgical technologies, zirconia ceramics, and biodegradable magnesium alloys, with strong translational impact in oral healthcare. She has authored 16 publications, received 128 citations, and holds an h-index of 7, reflecting a growing and credible research impact. Her research excellence is further demonstrated through high-impact journal publications, competitive national research grants, multiple international patents, and prestigious innovation and academic awards.

Citation Metrics (Scopus)

140

120

100

80

60

40

20

0

Citations 128

Documents 16

h-index 7


View Scopus Profile

Featured Publications


Method for accurately preparing cavities on cortical bones using picosecond laser
– Photobiomodulation, Photomedicine, and Laser Surgery, 2020

Yi Zhang | Health Sciences | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Yi Zhang | Health Sciences | Best Researcher Award 🏆

Director/Academic Vice President at Biotherapy Center, The First Affiliated Hospital of Zhengzhou University/Zhengzhou University School of Medical Sciences🎓

Prof. Yi Zhang is an internationally acclaimed expert in cell and tumor immunotherapy. Serving as Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, he also holds key leadership roles, including Academic Vice President of the Zhengzhou University School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. With 35 years of research experience across Belgium, the U.S., and China, Prof. Zhang has pioneered breakthrough therapies, such as genetically engineered CAR-T cells for solid tumors, and holds 16 patents. His work has made significant impacts in reducing immune suppression and improving cancer treatment efficacy worldwide.

Professional Profile 

Education 🎓:

Prof. Yi Zhang has a profound academic foundation in medical sciences, gained through decades of experience and study in Belgium, the United States, and China. His extensive education and training have built the groundwork for his pioneering research in cell and tumor therapy.

Work Experience 💼:

Prof. Zhang is the Director of the Biotherapy Center at The First Affiliated Hospital of Zhengzhou University, where he also serves as the Academic Vice President for Zhengzhou University’s School of Medical Sciences and Director of the Zhongyuan Cellular and Immunotherapy Laboratory. Over a 35-year career, he has developed innovative therapies and led cutting-edge research in cell therapy, accumulating extensive clinical and academic expertise.

 

Skills 🔍

Known for his skills in genetically engineered cell therapies, Prof. Zhang is a leader in cellular engineering, particularly CAR-T cell technology. His groundbreaking work includes discovering a therapeutic target for solid tumors and developing gene-editing techniques to improve immune responses. His practical expertise in cell culture, immune cell enhancement, and patent development make him a pioneer in clinical biotherapeutics.

Awards and Honors 🏆

Prof. Zhang has received acclaim globally, being listed among the world’s top 100,000 scientists and recognized by both domestic and international peers for his contributions to immunotherapy. He has successfully converted seven patents, raising over 80 million RMB in transfer amounts, and is frequently invited to international conferences as a distinguished chair or guest of honor.

🤝 Memberships:

Prof. Zhang holds numerous prominent roles, such as Chairman of the Committee on Tumor Immunity and Biotherapy, Chinese Society of Immunology, and Deputy Chairman of the Cancer Biological Therapy Committee under the China Anti-Cancer Association. He also plays leadership roles in the Henan Anticancer Association and Henan Immunological Society, reflecting his commitment to advancing cell therapy on a national and global scale.

Teaching Experience 👩‍🏫:

Prof. Zhang has contributed significantly to training the next generation of scientists, collaborating with international colleagues to co-train PhD students and mentor young researchers. His commitment to academic growth is evident through his regular academic exchanges and collaborative projects with institutions in Canada, the U.S., and Europe.

Research Focus 🔬:

Prof. Zhang’s research is concentrated on tumor immunotherapy and cellular therapy, focusing on advancing CAR-T cell therapies for cancer. His achievements include creating novel immune cell treatments, reducing PD-1 expression to combat immune suppression, and conducting over 52 clinical trials for new cancer therapies, with 29 specifically targeting solid tumors.

Conclusion 

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the award’s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhang’s work exemplifies the award’s spirit, making him a distinguished candidate for the Best Researcher Award.

📚 Publilcation

  • “LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8 + T cells for improving anti-PD-1 antibody therapy”
    • Year: 2024-12-31
    • Journal: OncoImmunology
  • “Characteristics and mechanisms of T‐cell senescence: A potential target for cancer immunotherapy”
    • Year: 2024-11
    • Journal: European Journal of Immunology
  • “CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis”
    • Year: 2024-10-03
    • Journal: Cancer Immunology Research
  • “A single-cell RNA-seq dataset describing macrophages in NSCLC tumor and peritumor tissues”
    • Year: 2024-10-01
    • Journal: Scientific Data
  • “Allogeneic CAR-T cells for cancer immunotherapy”
    • Year: 2024-09-24
    • Journal: Immunotherapy
  • “IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells”
    • Year: 2024-05-03
    • Journal: British Journal of Cancer
  • “Current advances in bacteria‐based cancer immunotherapy”
    • Year: 2024-02
    • Journal: European Journal of Immunology
  • “Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity”
    • Year: 2023-10-09
    • Journal: Cancer Biology & Medicine
  • “Immunosenescence: molecular mechanisms and diseases”
    • Year: 2023-05-13
    • Journal: Signal Transduction and Targeted Therapy
  • “Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells”
    • Year: 2023-04-28
    • Journal: Signal Transduction and Targeted Therapy

Achilleia-Maria Pavlou | Medicine and Dentistry | Best Researcher Award

Published on by Cognitive Scientist Awards

 Dr. Achilleia-Maria Pavlou | Medicine and Dentistry | Best Researcher Award

 Dr.Achilleia-Maria Pavlou,School of Dentistry, Aristotle University of Thessaloniki, Greece,Greece

 

Dr. Achilleia-Maria Pavlou is a distinguished academic at the School of Dentistry, Aristotle University of Thessaloniki, Greece. With a focus on advancing dental science and clinical practices, she has made significant contributions to her field through research, teaching, and professional development. Her expertise and commitment to dentistry are reflected in her ongoing efforts to improve patient care and educational outcomes within the dental community.

Professional Profile:

Academic and Professional Background:

I hold a DDS, MD, and MSc degrees, with a postgraduate thesis on the “Isolation and characterization of stem cells from minor salivary glands of the oral mucosa and their differentiation into insulin-producing pancreatic cells.” Currently, I am pursuing a PhD focusing on the molecular pathways of pancreatic differentiation in minor salivary gland stem cells. My academic journey includes a two-year residency in pathology and plans for a four-year residency in rheumatology.

Research and Innovations:

  • Daylight Photodynamic Therapy: Successfully completed a project exploring its efficacy in treating actinic cheilitis.
  • Pancreatic Differentiation: Ongoing research on the potential of minor salivary gland stem cells to differentiate into insulin-producing pancreatic cells.

Areas of Research:

  • Photodynamic therapy
  • Daylight photodynamic therapy
  • Actinic cheilitis
  • Human minor salivary gland stem cells
  • Pancreatic differentiation

Contributions:

  • My research has demonstrated that daylight photodynamic therapy can serve as a primary treatment for actinic cheilitis with grade I dysplasia, showing complete clinical response with minimal adverse effects. Additionally, my work has established the potential of minor salivary gland stem cells for pancreatic differentiation, which could advance diabetes mellitus treatments.

Publications: 

  • Andreadis D, Pavlou AM, Sotiriou E, Vrani F, Ioannides D, Kolokotronis A. “Utility of photodynamic therapy for the management of oral potentially malignant disorders and oral cancer.” Translational Research in Oral Oncology, 2016; 1: 1–19. DOI

 

  • Matiakis A, Karakostas P, Pavlou AM, Anagnostou E, Poulopoulos A. “Angioleiomyoma of the oral cavity: a case report and brief review of the literature.” J Korean Assoc Oral Maxillofac Surg., 2018; 44(3): 136-139. DOI

 

  • Andreadis D, Pavlou AM, Vakirlis E, Anagnostou E, Vrani F, Poulopoulos A, Kolokotronis A, Ioannidis D, Sotiriou E. “Daylight photodynamic therapy for the management of actinic cheilitis.” Arch Dermatol Res., 2020; 312(10): 731-737. DOI

 

  • Andreadis D, Pavlou AM, Vakirlis E, Anagnostou E, Vrani F, Poulopoulos A, Kolokotronis A, Ioannidis D, Sotiriou E. “Actinic cheilitis may resemble oral lichenoid-type lesions or discoid lupus erythematosus.” Arch Dermatol Res., 2021; 313(10): 891-892. DOI

 

  • Pavlou AM, Papachristou E, Bonovolias I, Anagnostou E, Anastasiadou P, Poulopoulos A, Bakopoulou A, Andreadis D. “Pancreatic Differentiation of Oral Minor Salivary Gland Stem Cells.” Stem Cell Rev Rep., 2024. DOI